Tilray (NASDAQ:TLRY) Trading Up 1.4%

Tilray Inc (NASDAQ:TLRY)’s stock price was up 1.4% on Friday . The company traded as high as $1.77 and last traded at $1.77. Approximately 3,958,579 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 25,007,477 shares. The stock had previously closed at $1.74.

Tilray Stock Performance

The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The company’s 50 day moving average is $1.80 and its 200-day moving average is $1.87. The company has a market capitalization of $1.48 billion, a P/E ratio of -4.01 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). The firm had revenue of $229.90 million during the quarter, compared to the consensus estimate of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.15) EPS. Equities analysts anticipate that Tilray Inc will post -0.16 EPS for the current fiscal year.

Institutional Trading of Tilray

Institutional investors have recently made changes to their positions in the business. Prospect Financial Services LLC bought a new position in shares of Tilray during the 2nd quarter valued at about $26,000. Wellington Wealth Strategies LLC. bought a new position in Tilray during the fourth quarter valued at $29,000. Signature Estate & Investment Advisors LLC bought a new stake in shares of Tilray in the 2nd quarter worth about $29,000. Jeppson Wealth Management LLC purchased a new stake in Tilray in the 2nd quarter worth about $33,000. Finally, Vanguard Capital Wealth Advisors purchased a new position in shares of Tilray during the second quarter valued at approximately $34,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.